1.14
+0.01(+0.88%)
Currency In USD
| Previous Close | 1.13 |
| Open | 1.14 |
| Day High | 1.16 |
| Day Low | 1.11 |
| 52-Week High | 737.5 |
| 52-Week Low | 1.03 |
| Volume | 63,881 |
| Average Volume | 2.86M |
| Market Cap | 854,250 |
| PE | 0 |
| EPS | -1,100.5 |
| Moving Average 50 Days | 2.87 |
| Moving Average 200 Days | 107.93 |
| Change | 0.01 |
If you invested $1000 in Windtree Therapeutics, Inc. (WINT) 10 years ago, it would be worth $0 as of April 19, 2025 at a share price of $1.14. Whereas If you bought $1000 worth of Windtree Therapeutics, Inc. (WINT) shares 5 years ago, it would be worth $0.04 as of April 19, 2025 at a share price of $1.14.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules
GlobeNewswire Inc.
Mar 24, 2025 12:00 PM GMT
WARRINGTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing early and late-stage innovative t
Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
GlobeNewswire Inc.
Mar 20, 2025 12:00 PM GMT
Transaction is part of the Company’s new corporate strategy to become a revenue generating biotechWARRINGTON, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology compan
Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure
GlobeNewswire Inc.
Mar 04, 2025 1:00 PM GMT
WARRINGTON, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and disea
Data not available